Back
Squarespace Vs. Summit Therapeutics Industry Stock Comparison
Buy
66
SQSP
Squarespace
Last Price:
46.40
Seasonality Move:
-19.94%
Buy
85
SMMT
Summit Therapeutics
Last Price:
26.20
Seasonality Move:
26.72%
Buy
66
Squarespace (SQSP)
is a Buy
Is Squarespace a Buy, Sell or Hold?
- The current Squarespace [SQSP] share price is $46.30. The Score for SQSP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- SQSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
85
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $29.48. The Score for SMMT is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
SQSP Stock Price Chart
What is Squarespace's stock price today?
-
The Squarespace share price today is $46.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SQSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $29.48
The current trend is moderately bullish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.
SQSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 77.46 | Buy |
| Chaikin Money Flow: | 964412 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.65 - 45.93) | Buy |
| Bollinger Bands (100): | (40.18 - 46.06) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.35 | Buy |
| Relative Strength Index (14 RSI): | 80.76 | Buy |
| Chaikin Money Flow: | -10383890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.54 - 21.66) | Buy |
| Bollinger Bands (100): | (4.24 - 14.54) | Buy |
SQSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.01 | Buy |
| 20-day SMA: | 45.47 | Buy |
| 50-day SMA: | 44.62 | Buy |
| 200-day SMA: | 37.8 | Buy |
| 8-day EMA: | 46.04 | Buy |
| 20-day EMA: | 45.55 | Buy |
| 50-day EMA: | 44.61 | Buy |
| 200-day EMA: | 39.2 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.3 | Buy |
| 20-day SMA: | 16.66 | Buy |
| 50-day SMA: | 12.66 | Buy |
| 200-day SMA: | 6.49 | Buy |
| 8-day EMA: | 23.98 | Buy |
| 20-day EMA: | 18.55 | Buy |
| 50-day EMA: | 13.95 | Buy |
| 200-day EMA: | 7.85 | Buy |
Squarespace Earnings Growth & SQSP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.17 per share, an increase this year of $0.39 per share, and an increase next year of $0.40 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.
Squarespace Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||